pemigatinib
innovent biologics,incyte
['pemazyre', 'pemigatinib', 'innovent']
dcbn news: innovent announces overall survival results of phase 2 study of pemazyre (pemigatinib) in chinese patients with advanced cholangiocarcinoma presented at aacr annual meeting 2023: rockville, md. ... #biotech #news 
Life science news and jobs from Washington DC, Maryland and Virginia. Part of @BiotechNetworks, connecting #biotech since 2008.